key: cord-1054756-43ch9uzt
authors: Cadd, Matthew; Nunn, Maya
title: An A-E assessment of post-ICU COVID-19 recovery
date: 2021-03-20
journal: J Intensive Care
DOI: 10.1186/s40560-021-00544-w
sha: 7fc3674bf14fb7251cadd1ad2f0d474cca6d6405
doc_id: 1054756
cord_uid: 43ch9uzt

The COVID-19 global pandemic has placed unprecedented strain on healthcare and critical care services around the world. Whilst most resources have focused on the acute phase of the disease, there is likely to be an untold burden of patients chronically affected. A wide range of sequelae contribute to post intensive care syndrome (PICS); from our current knowledge of COVID-19, a few of these have the potential to be more prevalent following critical care admission. Follow-up assessment, diagnosis and treatment in an increasingly virtual setting will provide challenges but also opportunities to develop these services. Here, we propose an A to E approach to consider the potential long-term effects of COVID-19 following critical care admission. Anxiety and other mental health diagnoses Breathlessness Central nervous system impairment Dietary insufficiency and malnutrition Embolic events Developing strategies to mitigate these during admission and providing follow-up, assessment and treatment of persistent multiple organ dysfunction will be essential to improve morbidity, mortality and patient quality of life.

Background COVID-19 has caused a global surge in critical care demand not previously seen in history. COVID-19 has the potential to have a protracted course, a significant number of patients show symptoms lasting more than 8 weeks [1, 2] . As more COVID-19 critical care survivors begin their recovery, there may be some unique features of post COVID-19 intensive care syndrome that will require ongoing assessment and follow-up. Here, we aim to provide some wider considerations of these based on the limited data from current post COVID-19 research and also extrapolated from longer term data from other critical care populations and notably previous respiratory virus pandemics.

Anxiety, depression and post-traumatic stress disorder (PTSD) are frequently seen following critical care admission; in pre-pandemic studies, 35-45% of patients met diagnostic criteria for anxiety 12 months following discharge and 18% meeting diagnostic criteria for all three diagnoses [3, 4] . Risk factors for developing mental health disorders following critical care admission include longer periods of mechanical ventilation and delirium [5] . Given COVID-19 patients are requiring longer periods of mechanical ventilation and sedation, combined with dexamethasone being used for treatment, these patients are predisposed to higher rates of delirium and subsequent mental health disorders [6, 7] . The effect of social isolation on patients, before, during and after critical care admission should be taken into account; a small number of studies have shown that loneliness and resulting depression has increased during the pandemic [8, 9] .

Additionally, there could be a direct neurological effect of the SARS-CoV-2 as was noted with SARS-CoV and MERS or indirect as part of the systemic sequalae of the disease [10] . Either way, there are reports of widespread neurological effects of COVID-19; a study from Wuhan found patients with more severe COVID-19 had higher rates of neurological outcomes (45% compared to 36% in those with less severe disease) [11] . A biological cause for mental health problems following infection should not be overlooked.

Critical care diaries have been shown to reduce PTSD; these would not only provide a story of their admission as documented by staff but could be used to communicate messages from relatives unable to visit during admission [12] .

Offering critical care follow-up to discuss specific concerns and screening for mental health disorders, in either a clinic or primary care setting, using a suitable questionnaire such as the GHQ-28, will be particularly important in post critical care COVID-19 patients [13] [14] [15] .

Breathlessness, reduced exercise tolerance and impaired pulmonary function were common amongst patients following the previous SARS epidemic and have been shown to cause considerable morbidity following COVID-19 [16, 17] . Anaemia, respiratory muscle dysfunction, deconditioning, pulmonary embolism and anxiety can all contribute to the often-multifactorial nature of post critical care breathlessness [18] . Early planning for rehabilitation whilst patients are still in critical care is important to have the greatest impact on recovery [19] .

Pulmonary rehabilitation (PR) aims to increase functional capacity, reduce symptoms and improve quality of life [18] . PR is multifaceted and requires patient education, psychosocial support, exercise prescription and medical optimisation.

Virtual PR has shown some early promise in COVID-19 patients, including video classes, booklets and telephone appointments [20] . Remote assessment with a 6-min walk test using a mobile application combined with a home pulse oximetry could be used to help stratify patients who need further input and face-to-face assessment [21, 22] .

Central nervous system impairment and particularly chemosensory disturbance has shown to be a common symptom of COVID-19. A recent meta-analysis has shown olfactory dysfunction and taste dysfunction to be present in 38.5% and 30.4% of COVID-19 patients, respectively [23] . As opposed to other viral causes of anosmia or hyposmia, it is thought that COVID-19 is neurotropic rather than causing nasal congestion [24, 25] .

Although some studies report anosmia as being indicative of less severe disease and lower mortality, a significant number of critical care patients still report chemosensory disturbance [26] . Critical care acquired weakness and loss of muscle mass may be exacerbated by lack of enjoyment in eating and subsequent malnutrition due to absent taste and smell [27] .

Although there is limited evidence in COVID-19 to date, olfactory training is a treatment that can be completed remotely and has shown to be effective for sensorineural olfactory loss [28] [29] [30] .

Dietary intake is an important consideration for all critical care patients. COVID-19 has presented its own challenges for providing nutrition to patients in critical care including debate around if nasogastric tube insertion is aerosol generating and potential challenges of enteral feeding in proned patients [31, 32] .

To date there have been no studies looking specifically at the nutritional status of COVID-19 critical care patients. As previously discussed, COVID-19 patients have required a prolonged length of stay compared to other critical care patients. This combined with the hypercatabolic state it induces put this group at higher risk of malnutrition and subsequent complications [6, 33] . Inadequate nutritional intake in critical care patients has shown to increase mortality and time to physical recovery [34] .

Post extubation dysphagia, critical care acquired weakness, anosmia and ageusia are factors that will make it challenging for patients to meet their nutritional requirements. A nutritional plan, with regular assessment and progressive physical exercise should be the mainstay of recovery [35] .

Embolic and thrombotic events have been more prevalent in the COVID-19 critical care population, 31% and 5% of patients have been shown to have venous and arterial thromboembolisms, respectively [36] [37] [38] [39] . COVID-19 has been shown to cause profound hypercoagulability, complement activation and cytokine storm [40, 41] , which can lead to widespread embolic events in the arterial and venous systems. Longer periods of immobility, staffing constraints and isolation restrictions may further increase clot risk [42] .

Pulmonary embolism, cerebrovascular accident, myocardial infarction and limb ischaemia can cause significant morbidity and mortality both immediately and chronically. Early adequate therapeutic anticoagulation and recognition of the aforementioned diagnosis will help to reduce clot burden whilst not increasing bleeding incidence [43, 44] .

Although no long-term data currently exists for embolic risk post COVID-19 (both in patients with confirmed VTE and those without), there should be risk stratification for further thrombosis and haemorrhagic risk and consideration of longer treatment or empirical anticoagulation [45] .

COVID-19 has so far shown to be a multi-organ disease affecting all ages. Although PICS is well-recognised in critical care survivors, there is limited evidence of the chronic effects of COVID-19 in post critical care patients at present [46] . We believe PICS will be prevalent following COVID-19 but the symptoms and diagnoses discussed here may be unique to COVID-19 and should be considered following critical care discharge.

As public health restrictions continue to be dynamic, the medium for providing assessment should minimise face to face contact so as to maintain some consistency in service provision. A wide-ranging multidisciplinary team both in primary and secondary care will be required to address the aforementioned sequalae and additional ones not discussed here. Current guidelines suggest rehabilitation assessment and initiation of treatment should start whilst patients remain in critical care [47] .

Treatment of these conditions are wide ranging from psychological to pharmacological. As more data emerges about specific complications in this patient group, treatment strategies and guidelines will be implemented and updated. More extensive guidelines have been produced elsewhere highlighting current best practice for on-going assessment and treatment of post-acute COVID-19 in the community setting [20] .

Multi-centre longitudinal studies are currently underway to assess the long-term impact of COVID-19 and the needs of COVID-19 patients who have been hospitalised. Analysis of these large studies should guide best practice [48] .

The unifying aim of assessing each of the aspects of post COVID-19 care is to adequately treat patients to reduce morbidity and mortality, improve quality of life and help enable patients to return to their previous baseline of physical and mental functionality. 

Persistent symptoms in patients after acute COVID-19

How long does COVID-19 last? Kings College London

Depression and Post Traumatic Stress Disorder after critical illness: a UKwide prospective cohort study

Anxiety symptoms in survivors of critical illness: a systematic review and meta-analysis

Long-term complications of critical care

Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region

Dexamethasone in hospitalized patients with Covid-19

Increases in loneliness among young adults during the COVID-19 pandemic and association with increases in mental health problems

COVID-19: Preliminary data on the impact of social distancing on loneliness and mental health

The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease

Intensive care diaries reduce new onset post traumatic stress disorder following critical illness: a randomised, controlled trial

A user's guide to the General Health Questionnaire

Stress and psychological distress among SARS survivors 1 year after the outbreak

How mental health care should change as a consequence of the COVID-19 pandemic

The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status

Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalisation

The Stanford Hall consensus statement for post

National Institute for Health and Care Excellence (NICE)

Management of post-acute covid-19 in primary care

The Mobile-Based 6-Minute Walk Test: Usability Study and Algorithm Development and Validation

Lung function testing in the COVID-19 endemic

Prevalence of chemosensory dysfunction in COVID-19 Patients: a systematic review and meta-analysis reveals significant ethnic differences

Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms

More than smell-COVID-19 is associated with severe impairment of smell, taste, and chemesthesis

Taste and Smell Impairment in Critically Ill Patients With COVID-19: An Intensive Care Unit Study

The ICM research agenda on intensive care unit-acquired weakness

A primer on viral-associated olfactory loss in the era of COVID-19

Efficacy of olfactory training in patients with olfactory loss: a systematic review and meta-analysis

Anosmia and loss of smell in the era of COVID-19

Should nasogastric tube insertion during the COVID-19 pandemic be considered as an aerosol-generating procedure?

Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines

Nutrition of the COVID-19 patient in the intensive care unit (ICU): a practical guidance

The association between nutritional adequacy and long-term outcomes in critically ill patients requiring prolonged mechanical ventilation: a multicenter cohort study

ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection

Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis

Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis

Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors

Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Thromboembolic disease in COVID-19 patients: A brief narrative review

ISTH interim guidance on recognition and management of coagulopathy in COVID-19

Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action

Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up

Post-intensive care syndrome: an overview

Rehabilitation in the wake of Covid-19-a phoenix from the ashes

The Post-hospitalisation COVID-19 study

Authors' contributions MC and MN have both contributed to, read and approved the final manuscript.

Availability of data and materials We have not collected or analysed any data.

Ethics approval and consent to participate Not applicable

We consent for the below manuscript to be published.

The authors declare that they have no competing interests.Received: 17 December 2020 Accepted: 7 March 2021